University of Minnesota. Driven to Discover.
Narrow results
Clinical trials will test a candidate vaccine for H7N9 flu in varying doses, some with immune boosters.
Experts say some properties of H7 viruses may lend themselves to human adaptation.
Get news & practices.
Sign up now»
Unrestricted financial support provided by
Become an underwriter»